G Protein News and Research

RSS

Antiverse raises funding and demonstrates therapeutic antibody identification with AI-driven drug discovery platform

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.

From Antiverse 1 Mar 2023

Study reveals how neural networks play a key role in the regulation of circadian rhythms

Circadian rhythms are inherent cycles of approximately 24 hours that regulate various biological processes, such as sleep and wakefulness.

19 Jan 2023

New molecular pathway critical to the initiation of pancreatic tumors discovered

Researchers at University of California San Diego School of Medicine have discovered a molecular pathway critical to the initiation of pancreatic tumors.

16 Jan 2023

The impact of the infant gut microbiome on vaccine efficacy

A new study reports the effect of the infant gut microbiome on vaccine efficacy.

13 Sep 2022

Improving 1 µL UV-Vis Spectrophotometry Sample Results

Prior to microvolume spectrophotometry, UV-Vis quantification of biomolecules was performed using quartz cuvettes with a 10mm pathlength.

From DeNovix Inc. 1 Sep 2022

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

Researchers identify and characterize the targets of Vit D on COVID-19 and osteoporosis.

30 Aug 2022

Johns Hopkins Medicine researchers challenge the prevailing belief on how nasal cells process scent

Johns Hopkins Medicine researchers say they have evidence to potentially overturn a prevailing belief in a type of important signaling within cells.

18 Aug 2022

Key gene sheds light on how people develop tolerance to pain-relievers over time

UF Scripps Biomedical Research scientists have a discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.

18 Aug 2022

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

In newly released research, scientists assessed the cardiac effects of remdesivir.

12 Aug 2022

Oligomeric molecular structure of the MOR-Gal1R complex revealed

A study published in the journal Pharmacological Research reveals the oligomeric molecular structure of the MOR-Gal1R complex, a component present in the brain which is involved in the analgesic and addictive effects of certain opioids.

22 Jul 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

Orbit Discovery awarded Innovate UK grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

Orbit Discovery Ltd., (“Orbit”) a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, has been awarded a Smart grant by Innovate UK, the UK’s innovation agency.

From Orbit Discovery 14 Jun 2022

Core body temperature increases host resistance to influenza virus and SARS-CoV-2 infection

A recent article posted to the Research Square* preprint server demonstrated that high body temperature elevates gut microbiota-reliant host resistance against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A viral infection.

10 Jun 2022

Potential new therapeutic target for pancreatic cancer discovered

Northwestern Medicine investigators have discovered that targeting the G alpha 13 protein in pancreatic tumors promotes tumor growth and progression, according to a study published in Cell Reports.

29 Mar 2022

Study shows chronic alcohol consumption as a potential risk factor for SARS-CoV-2-infection

In a study posted to the bioRxiv* preprint server, a team of researchers from Germany studied the expression data of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-relevant genes such as angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), and the G-protein coupled receptor Mas in an alcohol-exposed rodent model infected with SARS-CoV-2.

7 Feb 2022

G Protein News and Research

Antiverse raises funding and demonstrates therapeutic antibody identification with AI-driven drug discovery platform

Study reveals how neural networks play a key role in the regulation of circadian rhythms

New molecular pathway critical to the initiation of pancreatic tumors discovered

The impact of the infant gut microbiome on vaccine efficacy

Improving 1 µL UV-Vis Spectrophotometry Sample Results

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

Johns Hopkins Medicine researchers challenge the prevailing belief on how nasal cells process scent

Key gene sheds light on how people develop tolerance to pain-relievers over time

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

Oligomeric molecular structure of the MOR-Gal1R complex revealed

GPR183 gene a novel drug target for severe COVID-19

Orbit Discovery awarded Innovate UK grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

Core body temperature increases host resistance to influenza virus and SARS-CoV-2 infection

Potential new therapeutic target for pancreatic cancer discovered

Study shows chronic alcohol consumption as a potential risk factor for SARS-CoV-2-infection

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Research offers insights to restore blood vessel integrity during sepsis, other conditions

Study suggests a balanced approach to developing safer opioid analgesics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News